Ribosomal Protein L11 Inhibitors

Ribosomal Protein L11 (RPL11) inhibitors form a diverse class of chemicals that modulate the activity of RPL11 through direct or indirect mechanisms, influencing its interaction with 28S rRNA and subsequent assembly of the 60S ribosomal subunit. One example is CX-5461, a synthetic small molecule that acts as a direct inhibitor by binding to the G-quadruplex structure in the rRNA, preventing the interaction between L11 and 28S rRNA. This disrupts the assembly of the 60S ribosomal subunit, leading to inhibition of protein synthesis. Another direct inhibitor, BMH-21, binds to the C-terminal region of L11, illustrating its specific mechanism for inhibiting RPL11 and its downstream effects on ribosomal subunit assembly and protein translation. Additionally, CX-3543 and NSC 663284 serve as indirect inhibitors by modulating the G-quadruplex structure and promoting the dissociation of L11 from 28S rRNA, respectively. These indirect modulations disrupt the assembly of the 60S ribosomal subunit, leading to impaired protein synthesis. The class also includes compounds like Flavopiridol, CGP 57380, and Cisplatin, which act indirectly by inhibiting kinases responsible for L11 phosphorylation, further illustrating the diversity of mechanisms within this chemical class.

RK-33 and CX-5011 act as both direct and indirect inhibitors, binding to the G-quadruplex structure and stabilizing it, preventing L11 dissociation and disrupting ribosomal subunit assembly. Notably, Cisplatin forms covalent adducts with the C-terminal region of L11, showcasing a unique mechanism for inhibiting RPL11. These diverse mechanisms highlight the intricate regulatory network governing RPL11 activity and its critical role in protein synthesis. In summary, RPL11 inhibitors represent a class of chemicals with various mechanisms of action, all converging on the modulation of RPL11 and its role in ribosomal subunit assembly. Understanding the specific biochemical and cellular pathways influenced by these inhibitors provides valuable insights into the complexity of regulatory processes governing protein synthesis.